186 related articles for article (PubMed ID: 24307431)
1. Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.
Ingegnoli F; Tourlaki A; Gualtierotti R
Clin Drug Investig; 2014 Feb; 34(2):159-61. PubMed ID: 24307431
[TBL] [Abstract][Full Text] [Related]
2. [IL-6 blockade].
Kaneko Y; Takeuchi T
Nihon Rinsho; 2016 Jun; 74(6):963-7. PubMed ID: 27311186
[TBL] [Abstract][Full Text] [Related]
3. Is tocilizumab safe in Kaposi sarcoma? A complex association among rheumatoid arthritis, psoriasis, and Kaposi sarcoma.
Verdelli A; Bonciani D; Bonciolini V; Caproni M
Clin Drug Investig; 2014 Jun; 34(6):437-8. PubMed ID: 24811252
[No Abstract] [Full Text] [Related]
4. Tocilizumab (Actemra).
Sheppard M; Laskou F; Stapleton PP; Hadavi S; Dasgupta B
Hum Vaccin Immunother; 2017 Sep; 13(9):1972-1988. PubMed ID: 28841363
[TBL] [Abstract][Full Text] [Related]
5. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.
Raimondo MG; Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2017; 11():1593-1603. PubMed ID: 28579757
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous tocilizumab for the treatment of rheumatoid arthritis.
Mitchell E; Jones G
Expert Rev Clin Immunol; 2016; 12(2):103-14. PubMed ID: 26629984
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2019; 13():57-70. PubMed ID: 30587928
[TBL] [Abstract][Full Text] [Related]
8. [Tocilizumab in rheumatoid arthritis].
Rueda Gotor J; Blanco Alonso R
Reumatol Clin; 2011 Mar; 6S3():S29-32. PubMed ID: 21794769
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab for the treatment of rheumatoid arthritis.
Tanaka T; Ogata A; Narazaki M
Expert Rev Clin Immunol; 2010 Nov; 6(6):843-54. PubMed ID: 20979549
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
Tanaka E; Inoue E; Hoshi D; Shimizu Y; Kobayashi A; Sugimoto N; Shidara K; Sato E; Seto Y; Nakajima A; Momohara S; Taniguchi A; Yamanaka H
Mod Rheumatol; 2015 Jul; 25(4):503-13. PubMed ID: 25547018
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis.
Zhang X; Peck R
Expert Rev Clin Pharmacol; 2011 Sep; 4(5):539-58. PubMed ID: 22114882
[TBL] [Abstract][Full Text] [Related]
12. Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?
Moots RJ; Ostör AJ; Isaacs JD
Expert Opin Investig Drugs; 2009 Nov; 18(11):1687-99. PubMed ID: 19715449
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab: A Review in Rheumatoid Arthritis.
Scott LJ
Drugs; 2017 Nov; 77(17):1865-1879. PubMed ID: 29094311
[TBL] [Abstract][Full Text] [Related]
14. [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)].
Nasonov EL
Ter Arkh; 2010; 82(5):64-71. PubMed ID: 20597275
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab: a review of its use in the management of rheumatoid arthritis.
Oldfield V; Dhillon S; Plosker GL
Drugs; 2009; 69(5):609-32. PubMed ID: 19368420
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab in the treatment of adult rheumatoid arthritis.
Sanmartí R; Ruiz-Esquide V; Bastida C; Soy D
Immunotherapy; 2018 Mar; 10(6):447-464. PubMed ID: 29495891
[TBL] [Abstract][Full Text] [Related]
17. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
Maini RN; Taylor PC; Szechinski J; Pavelka K; Bröll J; Balint G; Emery P; Raemen F; Petersen J; Smolen J; Thomson D; Kishimoto T;
Arthritis Rheum; 2006 Sep; 54(9):2817-29. PubMed ID: 16947782
[TBL] [Abstract][Full Text] [Related]
18. The clinical efficacy of tocilizumab in rheumatoid arthritis.
Mircic M; Kavanaugh A
Drugs Today (Barc); 2009 Mar; 45(3):189-97. PubMed ID: 19436841
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis.
Carbone G; Wilson A; Diehl SA; Bunn J; Cooper SM; Rincon M
Int J Biol Sci; 2013; 9(3):279-88. PubMed ID: 23493630
[TBL] [Abstract][Full Text] [Related]
20. The role of tocilizumab in the management of rheumatoid arthritis.
Ash Z; Emery P
Expert Opin Biol Ther; 2012 Sep; 12(9):1277-89. PubMed ID: 22849354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
